Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Net Margin (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Net Margin for 6 consecutive years, with 110.77% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 685.0% to 110.77% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 140.3% through Dec 2025, up 2685.0% year-over-year, with the annual reading at 140.3% for FY2025, 2685.0% up from the prior year.
  • Net Margin hit 110.77% in Q4 2025 for Rapid Micro Biosystems, up from 146.78% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 110.77% in Q4 2025 to a low of 486.47% in Q1 2021.
  • Historically, Net Margin has averaged 249.98% across 5 years, with a median of 232.09% in 2021.
  • Biggest YoY gain for Net Margin was 20850bps in 2021; the steepest drop was -16158bps in 2021.
  • Year by year, Net Margin stood at 280.43% in 2021, then plummeted by -34bps to 376.02% in 2022, then soared by 53bps to 176.3% in 2023, then skyrocketed by 33bps to 117.62% in 2024, then rose by 6bps to 110.77% in 2025.
  • Business Quant data shows Net Margin for RPID at 110.77% in Q4 2025, 146.78% in Q3 2025, and 163.29% in Q2 2025.